PORTFOLIO NEWS: TechCrunch: Duffl’s David Lin dishes on why traditional rapid grocery delivery is not working  Read More

BROADCAST: Consumers are ‘Frontloading’ Holiday Spending: Larry Cheng on Fox Business  Read More

TEAM NEWS: Tomy Han Ranked #24 on the Insider 71 rising-star VCs who shook up the industry in 2022  Read More

ANALYSIS: Rule of 40 Index, now live with time series data: Explore

VOLITION VIEWPOINTS: Five Ways to Build a Sustainable Execution Strategy (Hint: Be A Thermostat, Not A Thermometer)  Read More

TEAM NEWS: Volition Capital Vice President Claude de Jocas Named a 2022 Top Women Leader in Growth Investing  Read More

Volition Capital Announces Closing of Fund V with $675M in Capital Commitments: Volition Capital Announces Closing of Volition Capital Fund V, L.P. with $675M in Capital Commitments  Read More

Supply Chain

< 1

CNBC: TraceLink CEO Shabbir Dahod on securing the Covid-19 vaccine supply chain

Shabbir Dahod, CEO of our portfolio company, TraceLink, recently joined CNBC’s Worldwide Exchange to discuss the process of securing the supply chain for the Covid-19 vaccine rollout.

TraceLink has been involved in securing the pharmaceutical supply chain for over a decade, and Shabbir has extensive knowledge of the challenges that will arise as various COVID-19 vaccines begin to disseminate.

In fact, TraceLink has built the largest track and trace network in the world for pharmaceutical drugs, with over 280,000 entities, which gives it tremendous insight into this process.

Watch the entire interview on CNBC here!

ALL ARTICLES
BACK TO TOP